Add to ORKGCA15-3 is a high-molecular-mass mucin-like glycoprotein expres¬sed at the luminal surface of most secretary epithelia and associated with mammary tumors (Taylor et al., 2002). Increased levels were observe
A new tumour marker, mucin-like carcinoma-associated antigen (MCA), was evaluated in 176 breast canc...
This is the first comparison of the three mucin based tests CA15-3, CASA, and MSA, and the cytokerat...
mined in the serum of 56 patients with metastatic breast can-cer, all of whom had visceral and/or bo...
The Breast Cancer Mucin (BCM) enzyme immunoassay utilizes two monoclonal antibodies (Mab), M85/34 an...
Background: Much research is being carried out to find a tumor marker for early diagnosis of breast ...
Serum levels of CA 15-3 were measured in 778 samples from 270 patients with benign and malignant gyn...
Background: Breast cancer makes the major burden of carcinomas in females. Timely diagnosis and trea...
The relationship between mucin markers and several clinical and pathological characteristics was inv...
In order to study the relationship between circulating levels of CA 15-3 and the disease extent in p...
Data currently available are insufficient to demonstrate a real utility for CA 15-3 in the diagnosis...
Background: Breast cancer is the most frequently diagnosed type of cancer in women in all world regi...
Everolimus and exemestane represent a standard treatment for metastatic hormone receptor-positive/HE...
Abstract: Breast cancer is by far the most frequent cancer in women, worldwide and ranks third overa...
Introduction: Serum CA15-3 has been one of the most reliable tumor markers used in monitoring of bre...
Various studies have been searching for new tumor biomarkers for breast cancer for years. However, s...
A new tumour marker, mucin-like carcinoma-associated antigen (MCA), was evaluated in 176 breast canc...
This is the first comparison of the three mucin based tests CA15-3, CASA, and MSA, and the cytokerat...
mined in the serum of 56 patients with metastatic breast can-cer, all of whom had visceral and/or bo...
The Breast Cancer Mucin (BCM) enzyme immunoassay utilizes two monoclonal antibodies (Mab), M85/34 an...
Background: Much research is being carried out to find a tumor marker for early diagnosis of breast ...
Serum levels of CA 15-3 were measured in 778 samples from 270 patients with benign and malignant gyn...
Background: Breast cancer makes the major burden of carcinomas in females. Timely diagnosis and trea...
The relationship between mucin markers and several clinical and pathological characteristics was inv...
In order to study the relationship between circulating levels of CA 15-3 and the disease extent in p...
Data currently available are insufficient to demonstrate a real utility for CA 15-3 in the diagnosis...
Background: Breast cancer is the most frequently diagnosed type of cancer in women in all world regi...
Everolimus and exemestane represent a standard treatment for metastatic hormone receptor-positive/HE...
Abstract: Breast cancer is by far the most frequent cancer in women, worldwide and ranks third overa...
Introduction: Serum CA15-3 has been one of the most reliable tumor markers used in monitoring of bre...
Various studies have been searching for new tumor biomarkers for breast cancer for years. However, s...
A new tumour marker, mucin-like carcinoma-associated antigen (MCA), was evaluated in 176 breast canc...
This is the first comparison of the three mucin based tests CA15-3, CASA, and MSA, and the cytokerat...
mined in the serum of 56 patients with metastatic breast can-cer, all of whom had visceral and/or bo...